Product Categories
Country: | United States |
---|---|
Tel: | +1-781-999-5354 |
Mobile: | +1-00000000000 |
E-mail: | info@targetmol.com |
QQ: | |
Skype: | Chat Now! |
Address: | 36 Washington Street, Wellesley Hills |
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
Product Name | MF | CAS | Details |
---|
5-Iodo-indirubin-3'-monoxime | C16H10IN3O2 | 331467-03-9 | Details |
5-R-Rivaroxaban | C19H18ClN3O5S | 865479-71-6 | Details |
p-Ethynylphenylalanine;4-Ethynyl-L-phenylalanine | C11H11NO2 | 278605-15-5 | Details |
4-Hydroxynonenal;4-HNE | C9H16O2 | 75899-68-2 | Details |
Anti-inflammatory agent 1 | C17H16O3S | 1096621-42-9 | Details |
CCR3 antagonist 1 | C19H21Cl2N3O4S2 | 879399-82-3 | Details |
42-(2-Tetrazolyl)rapamycin | C52H79N5O12 | 221877-56-1 | Details |
3-Deazaadenosine hydrochloride | C11H15ClN4O4 | 86583-19-9 | Details |
(2S,3S)-E1R | C13H16N2O2 | 1424832-57-4 | Details |
2'-Deoxypseudoisocytidine | C9H13N3O4 | 65358-18-1 | Details |
(3S,5R)-Pitavastatin calcium | C25H26CaFNO4 | 254452-88-5 | Details |
4-Desmethyl Istradefylline | C19H22N4O4 | 160434-48-0 | Details |
PSN-GK1 | C20H23FN2O4S2 | 745051-61-0 | Details |
Antiasthmatic Compound 1 | C14H9NO5 | 63768-49-0 | Details |
TRPV antagonist 1 | C26H21F3N2O4S | 1192871-27-4 | Details |
5-HT1A modulator 1 | C21H25N3O2S | 142477-34-7 | Details |
5-A-RU hydrochloride;5-Amino-6-(D-ribitylamino)uracil hydrochloride | C9H17ClN4O6 | 134452-11-2 | Details |
E1R | C13H16N2O2 | 1301211-78-8 | Details |
QF0301B | C23H28N2O2 | 149247-12-1 | Details |
Anti-neurodegeneration agent 1 | C14H20ClN3O3 | 289893-23-8 | Details |
3,4-Dihydroxybenzylamine hydrobromide;NSC 263475 hydrobromide | C7H10BrNO2 | 16290-26-9 | Details |
5-HT4 antagonist 1 | C23H36N4O5S | 261766-73-8 | Details |
3-Nitrocoumarin | C9H5NO4 | 28448-04-6 | Details |
3-CPs;3-Carbethoxypsoralen | C14H10O5 | 20073-24-9 | Details |
4-Hydroxyacetophenone oxime | C8H9NO2 | 34523-34-7 | Details |
5-HT3 antagonist 3 | C20H21N3O | 120635-47-4 | Details |
3-arylisoquinolinamine derivative | C18H19N3O | 1029008-71-6 | Details |
24R-Calcipotriol;PRI 2202 | C27H40O3 | 112827-99-3 | Details |
5-Dehydroepisterol | C28H44O | 23582-83-4 | Details |
Regorafénib N-oxyde (M2) | C21H15ClF4N4O4 | 835621-11-9 | Details |
3'-Azido-3'-deoxy-5-methylcytidine | C10H14N6O4 | 1282040-14-5 | Details |
PGS-IN-1;KME-4 | C19H26O3 | 102271-49-8 | Details |
Antiulcer Agent 1 | C19H23N3O4 | 76001-09-7 | Details |
Acebutolol hydrochloride;Acebutolol HCl | C18H29ClN2O4 | 34381-68-5 | Details |
3-Hydroxy-4-methoxyacetophenone;Acetoisovanillone | C9H10O3 | 6100-74-9 | Details |
4'-Methylchrysoeriol | C17H14O6 | 4712-12-3 | Details |
5-HT7 agonist 1 | C19H20ClN3 | 334974-31-1 | Details |
3-O-Methyltolcapone;Ro 40-7591 | C15H13NO5 | 134612-80-9 | Details |
24-Norursodeoxycholic acid;nor-UDCA | C23H38O4 | 99697-24-2 | Details |
3-Oxo Atorvastatin | C33H33FN2O5 | 887196-30-7 | Details |
(3S,5S)-Pitavastatin calcium | C25H26CaFNO4 | 254452-92-1 | Details |
3-Hydroxy agomelatine D3 | C15H17NO3 | 1079774-23-4 | Details |
5-Lipoxygenase-In-1 | C23H28N4O2S | 125235-15-6 | Details |
MCHR1 antagonist 1 | C28H33F2N5O5 | 391610-37-0 | Details |
3α-Hydroxymogrol | C30H52O4 | 1343402-73-2 | Details |
(2R,3S)-E1R | C13H16N2O2 | 1424832-60-9 | Details |
Itraconazole;R51211 | C35H38Cl2N8O4 | 84625-61-6 | Details |
4-Hydroxypropranolol hydrochloride;(±)-4-hydroxy Propranolol hydrochloride | C16H21NO3.ClH | 14133-90-5 | Details |
4,7,10,13,16-Docosapentaenoic acid | C22H34O2 | 2313-14-6 | Details |
4-Diethylaminobenzaldehyde | C11H15NO | 120-21-8 | Details |
4-Hydroxyderricin | C21H22O4 | 55912-03-3 | Details |
(5E,9E,13E)-Teprenone;(5E,9E,13E)-Geranylgeranylacetone | C23H38O | 3796-63-2 | Details |
D-α-Tocopherol acetate;Vitamin E Acetate;Tocopherol acetate | C31H52O3 | 58-95-7 | Details |
(3S,5R)-Rosuvastatin | C22H28FN3O6S | 1242184-42-4 | Details |
4-Hydroxymephenytoin | C12H14N2O3 | 61837-65-8 | Details |
Calcium channel-modulator-1 | C26H24Cl2N2O7S | 136941-70-3 | Details |
11β-HSD1-IN-1 | C18H14ClF4N3O | 1203956-47-1 | Details |
Estrone;Fluoroethyl;Oestrone;Aquacrine | C18H22O2 | 53-16-7 | Details |
(2R,4R)-APDC | C6H10N2O4 | 169209-63-6 | Details |
(3S,5R)-Fluvastatin D6 sodium;(3S,5R)-XU 62-320 D6 | C24H27FNNaO4 | 2249799-35-5 | Details |
4-Methylamino antipyrine | C12H15N3O | 519-98-2 | Details |
5-A-RU;5-Amino-6-(D-ribitylamino)uracil | C9H16N4O6 | 17014-74-3 | Details |
3'-?O-?Acetylhamaudol | C17H18O6 | 30358-88-4 | Details |
3-Bromocytisine;3-Br-cytisine | C11H13BrN2O | 207390-14-5 | Details |
4-Methylamino antipyrine hydrochloride | C12H16ClN3O | 856307-27-2 | Details |
VEGFR-2-IN-9;KDR-in-4 | C23H25N3O3 | 408502-06-7 | Details |
(2S,3R)-Voruciclib | C22H19ClF3NO5 | 1253731-24-6 | Details |
3-O-Acetylbufotalin | C28H38O7 | 4029-69-0 | Details |
4'-Ethynyl-2'-deoxyadenosine | C12H13N5O3 | 306305-07-7 | Details |
5-Hydroxypyrazine-2-Carboxylic Acid | C5H4N2O3 | 34604-60-9 | Details |
3,3'-Diiodo-L-thyronine;3,3'-T2 | C15H13I2NO4 | 4604-41-5 | Details |
48740 RP;RP-55778 | C12H11N3OS | 93363-11-2 | Details |
4-O-Methyl honokiol | C19H20O2 | 68592-15-4 | Details |
4-Hydroxypropranolol-d7 hydrochloride;4-Hydroxypropranolol D7 hydrochloride;(±)-4-hydroxy Propranolol D7 hydrochloride | C16H15ClD7NO3 | 1219804-03-1 | Details |
24-Hydroxycholesterol | C27H46O2 | 30271-38-6 | Details |
2614W94 | C15H11F3O4S | 205187-35-5 | Details |
MAO-B-IN-1 | C16H14F3N3O2S | 1124198-17-9 | Details |
3-Carene | C10H16 | 13466-78-9 | Details |
4'-Raloxifene-β-D-glucopyranoside | C34H37NO9S | 334758-19-9 | Details |
Verapamil hydrochloride;Calcan hydrochloride;Manidon;Verapamil HCl;(±)-Verapamil hydrochlorid | C27H39ClN2O4 | 152-11-4 | Details |
Amikacin;Amikacine;Amikacina;Amikacinum | C22H43N5O13 | 37517-28-5 | Details |
3-Bromo-7-nitroindazole | C7H4BrN3O2 | 74209-34-0 | Details |
(3S,5R)-Fluvastatin sodium;(3S,5R)-XU 62-320 | C24H25FNNaO4 | 94061-81-1 | Details |
3-Hydroxy agomelatine | C15H17NO3 | 166526-99-4 | Details |
Lipid peroxidation inhibitor 1 | C24H32N2O | 142873-41-4 | Details |
4-Acetylsimvastatin | C27H40O6 | 145576-25-6 | Details |
(2R,3R)-E1R | C13H16N2O2 | 1400888-63-2 | Details |
4-Hydroxyatomoxetine D3 | C17H21NO2 | 1217686-14-0 | Details |
3-Deazaadenosine | C11H14N4O4 | 6736-58-9 | Details |
Fluorothyl;Flurothyl;Bis(2,2,2-trifluoroethyl) ether;Fluoroethyl | C4H4F6O | 333-36-8 | Details |
4-Acetamidophenyl acetate | C10H11NO3 | 2623-33-8 | Details |
264W94 | C23H31NO4S | 178961-24-5 | Details |
5,6-Dihydroxyindole | C8H7NO2 | 3131-52-0 | Details |
(3R,5S)-Atorvastatin sodium | C33H34FN2O5.Na | 131275-93-9 | Details |
(3R,5R)-Rosuvastatin | C22H28FN3O6S | 1094100-06-7 | Details |
4-Desmethoxy Omeprazole | C16H17N3O2S | 110374-16-8 | Details |
Substance P Receptor Antagonist 1 | C24H29F3N2O2 | 225526-17-0 | Details |
4-Bromo A23187;4-?Bromo A23187 | C29H36BrN3O6 | 76455-48-6 | Details |
4-Hydroxyatomoxetine | C17H21NO2 | 435293-66-6 | Details |
(3R,4R)-A2-32-01 | C19H27NO2 | 1359752-95-6 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 |